A clinical trial to study the cognitive impairment in persons with drug resistant epilepsy on anti seizure medications
Not Applicable
- Conditions
- Health Condition 1: G409- Epilepsy, unspecified
- Registration Number
- CTRI/2024/05/066894
- Lead Sponsor
- AIIMS, New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Person diagnosed with epilepsy on the basis of ILAE criteria.
2. Subject willing to participate and able to provide written informed consent.
3. Subject with basic understanding of Hindi or English.
Exclusion Criteria
1. Patients who are unwilling to participate and do not provide written informed consent.
2. Alcohol consumption.
3. Pregnant and lactating women.
4. History of other chronic communicable/noncommunicable, medical illness.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. MoCA Score <br/ ><br>2. ACE-III Score <br/ ><br>3. Serum biomarkers for BDNF, Homocysteine, Pyridoxine.Timepoint: Baseline
- Secondary Outcome Measures
Name Time Method To assess domainwise cognitive impairment.Timepoint: Baseline